Clinical and laboratory characteristics associated with dyslipidemia and liver steatosis in chronic HBV carriers.
about
Peroxisome Proliferators Activated Receptor (PPAR) agonists activate hepatitis B virus replication in vivo.PNPLA3 rs1010023 Predisposes Chronic Hepatitis B to Hepatic Steatosis but Improves Insulin Resistance and Glucose Metabolism.Thyroid function is associated with non-alcoholic fatty liver disease in chronic hepatitis B-infected subjects.
P2860
Clinical and laboratory characteristics associated with dyslipidemia and liver steatosis in chronic HBV carriers.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Clinical and laboratory charac ...... tosis in chronic HBV carriers.
@en
Clinical and laboratory charac ...... tosis in chronic HBV carriers.
@nl
type
label
Clinical and laboratory charac ...... tosis in chronic HBV carriers.
@en
Clinical and laboratory charac ...... tosis in chronic HBV carriers.
@nl
prefLabel
Clinical and laboratory charac ...... tosis in chronic HBV carriers.
@en
Clinical and laboratory charac ...... tosis in chronic HBV carriers.
@nl
P2093
P2860
P1476
Clinical and laboratory charac ...... tosis in chronic HBV carriers.
@en
P2093
Angélica Luciana Nau
Esther Buzaglo Dantas-Corrêa
Janaína Luz Narciso-Schiavon
Júlia Cristina Soares
Leonardo de Lucca Schiavon
Maria Beatriz Cacese Shiozawa
P2860
P304
P356
10.1590/0037-8682-0009-2014
P577
2014-03-01T00:00:00Z